{"id":"https://openalex.org/W2401437795","doi":null,"title":"Efficacy and Safety of Entacapone in the Patients with Parkinson's Disease Experiencing Wearing-off Phenomenon: Multicenter Randomized Placebo-controlled Double Blind Study","display_name":"Efficacy and Safety of Entacapone in the Patients with Parkinson's Disease Experiencing Wearing-off Phenomenon: Multicenter Randomized Placebo-controlled Double Blind Study","publication_year":2005,"publication_date":"2005-01-01","ids":{"openalex":"https://openalex.org/W2401437795","mag":"2401437795"},"language":"en","primary_location":{"id":"pmh:oai:CiteSeerX.psu:10.1.1.560.2566","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.560.2566","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://bbs.neuro.or.kr/space/journal/2005/200502011.pdf","raw_type":"text"},"parent_works":[],"lineage":["https://openalex.org/W2401437795"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112142532","display_name":"Joo\u2010Hyuk Im","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joo\u2010Hyuk Im","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031286966","display_name":"Joon-Kyoon Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joon-Kyoon Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047227996","display_name":"Sun-Ju Chung","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sun-Ju Chung","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108428068","display_name":"Beom S. Jeon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Beom S. Jeon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028821955","display_name":"Jin\u2010Hwan Cho","orcid":"https://orcid.org/0009-0005-4471-7307","observed_orcids":["https://orcid.org/0009-0005-4471-7307"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jin\u2010Hwan Cho","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-4471-7307","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067707745","display_name":"Myung Sik Lee","orcid":"https://orcid.org/0000-0002-8413-1854","observed_orcids":["https://orcid.org/0000-0002-8413-1854"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Myung Sik Lee","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8413-1854","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011624854","display_name":"Eun-Kyoung Cho","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eun-Kyoung Cho","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Won\u2010Young Lee","orcid":"https://orcid.org/0000-0002-1082-7592","observed_orcids":["https://orcid.org/0000-0002-1082-7592"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Won\u2010Young Lee","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1082-7592","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059199171","display_name":"Eun-Ah Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eun-Ah Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100742645","display_name":"Jae Woo Kim","orcid":"https://orcid.org/0000-0001-5456-9495","observed_orcids":["https://orcid.org/0000-0001-5456-9495"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jae Woo Kim","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5456-9495","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109144344","display_name":"Myoung C. Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Myoung C. Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2138,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.56077627,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"23","issue":"2","first_page":"206","last_page":"214"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10863","display_name":"Voice and Speech Disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3616","display_name":"Speech and Hearing"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/entacapone","display_name":"entacapone","score":1.0},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9890000224113464},{"id":"https://openalex.org/keywords/wearing-off-phenomenon","display_name":"wearing-off phenomenon","score":0.9829999804496765},{"id":"https://openalex.org/keywords/catechol-o-methyltransferase-inhibitors","display_name":"catechol-O-methyltransferase inhibitors","score":0.8930000066757202},{"id":"https://openalex.org/keywords/levodopa","display_name":"levodopa","score":0.871999979019165},{"id":"https://openalex.org/keywords/levodopa-dose-reduction","display_name":"levodopa dose reduction","score":0.8360000252723694},{"id":"https://openalex.org/keywords/on-off-time","display_name":"on-off time","score":0.6179999709129333},{"id":"https://openalex.org/keywords/motor-symptoms","display_name":"motor symptoms","score":0.4320000112056732},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.8389999866485596}],"concepts":[{"id":"https://openalex.org/C2776976799","wikidata":"https://www.wikidata.org/wiki/Q416444","display_name":"Entacapone","level":5,"score":0.9972645044326782},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8214138746261597},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7894859313964844},{"id":"https://openalex.org/C2780304432","wikidata":"https://www.wikidata.org/wiki/Q300989","display_name":"Levodopa","level":4,"score":0.7068048715591431},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.6595743298530579},{"id":"https://openalex.org/C2780405171","wikidata":"https://www.wikidata.org/wiki/Q629444","display_name":"Dyskinesia","level":4,"score":0.5716280937194824},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5310937166213989},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4888012111186981},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.42385250329971313},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37348097562789917},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.10915187001228333},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:CiteSeerX.psu:10.1.1.560.2566","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.560.2566","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://bbs.neuro.or.kr/space/journal/2005/200502011.pdf","raw_type":"text"},{"id":"mag:2401437795","doi":null,"is_oa":false,"landing_page_url":"https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001119943","pdf_url":null,"source":{"id":"https://openalex.org/S2764848346","display_name":"Journal of the Korean Neurological Association","issn_l":"1225-7044","issn":["1225-7044","2288-985X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["kci-registered"],"host_organization":"https://openalex.org/P4324031397","host_organization_name":"Korean Neurological Association","host_organization_lineage":["https://openalex.org/P4324031397"],"host_organization_lineage_names":["Korean Neurological Association"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of the Korean Neurological Association","raw_type":null},{"id":"mag:2940824988","doi":null,"is_oa":false,"landing_page_url":"https://ir.ymlib.yonsei.ac.kr/bitstream/22282913/151364/1/T200501215.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W133512341","https://openalex.org/W634747600","https://openalex.org/W1980384054","https://openalex.org/W1984439185","https://openalex.org/W1984593979","https://openalex.org/W1984702297","https://openalex.org/W1988308191","https://openalex.org/W1991080312","https://openalex.org/W1992465464","https://openalex.org/W2007297814","https://openalex.org/W2012060986","https://openalex.org/W2017055459","https://openalex.org/W2020613687","https://openalex.org/W2022635719","https://openalex.org/W2023195487","https://openalex.org/W2036145467","https://openalex.org/W2043589638","https://openalex.org/W2049451636","https://openalex.org/W2062890566","https://openalex.org/W2064996887","https://openalex.org/W2077878281","https://openalex.org/W2083272173","https://openalex.org/W2083637059","https://openalex.org/W2084669272","https://openalex.org/W2118896395","https://openalex.org/W2119257560","https://openalex.org/W2154764930","https://openalex.org/W2167760423","https://openalex.org/W2170999819","https://openalex.org/W2993523777","https://openalex.org/W3002001223"],"related_works":["https://openalex.org/W7034844212","https://openalex.org/W1992465464","https://openalex.org/W1598813848","https://openalex.org/W2088894800","https://openalex.org/W2119257560","https://openalex.org/W2141352228","https://openalex.org/W1988266165","https://openalex.org/W2036145467","https://openalex.org/W2047940641","https://openalex.org/W1984593979"],"abstract_inverted_index":{"Background:":[0],"The":[1,69,108,128,182],"purpose":[2],"of":[3,13,30,76,88,110,130,187],"this":[4,37],"study":[5],"was":[6,53,71,134,165],"to":[7,56,67],"assess":[8],"the":[9,74,86,89,99,105,119,125,140,146,158,162,169,176,188],"efficacy":[10,70],"and":[11,79,98,184],"safety":[12],"entacapone,":[14],"a":[15,47,154],"catechol-O-methyltransferase":[16],"(COMT)":[17],"inhibitor":[18],"in":[19,36,118,124,139,145,168],"Parkinson's":[20,93],"disease":[21],"(PD)":[22],"patients":[23,33],"with":[24,73,175],"wearing-off":[25],"phenomenon.":[26],"Methods:":[27],"A":[28],"total":[29,183],"197":[31],"PD":[32],"were":[34,190],"included":[35],"2-month":[38],"multi-center,":[39],"randomized,":[40],"placebo-controlled,":[41],"double":[42],"blind,":[43],"parallel-group":[44],"study.":[45],"After":[46],"2-week":[48],"screening":[49],"period,":[50],"each":[51],"patient":[52],"randomly":[54],"allocated":[55],"receive":[57],"either":[58],"entacapone":[59,120,141,170],"(n=98)":[60],"or":[61],"placebo":[62,126,147,177],"(n=99)":[63],"as":[64],"an":[65],"adjunct":[66],"levodopa.":[68],"evaluated":[72],"changes":[75],"\u201con":[77,111],"\u201d":[78,81,112,132],"\u201coff":[80,131],"time":[82,113,133],"percentage":[83,109,129],"while":[84],"awake,":[85],"reduction":[87],"levodopa":[90,163],"dose,":[91],"Unified":[92],"Disease":[94],"Rating":[95],"Scale":[96],"(UPDRS),":[97],"clinical":[100],"global":[101],"impression":[102],"(CGI)":[103],"by":[104,115,136],"examiner.":[106],"Results:":[107],"increased":[114],"9.4\u00b118.0":[116],"%":[117,123,138,144],"group,":[121,142],"7.4\u00b115.6":[122],"group.":[127,148],"reduced":[135,167],"8.6\u00b116.9":[137],"6.6\u00b118.2":[143],"These":[149],"parameters":[150],"did":[151],"not":[152],"show":[153],"statistical":[155],"significance":[156],"between":[157],"two":[159],"groups.":[160],"However,":[161],"dose":[164],"significantly":[166,191],"group":[171,178],"(51.6\u00b1154.5":[172],"mg/day)":[173,180],"compared":[174],"(0.7\u00b1130.0":[179],"(p=0.009).":[181],"motor":[185],"scores":[186],"UPDRS":[189]},"counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}